Tilray (NASDAQ: TLRY), Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) and Cronos Group (NASDAQ: CRON) were recently noted as three pure-play marijuana stocks currently listed on U.S. stock exchanges in an article on Fool.com titled, “The Marijuana Stock That Wall Street Likes the Most” authored by Keith Speights. Per the article, Tilray has been ranked as a “strong buy” by analysts at Cowen & Company, Northland Capital, and Roth Capital. Zacks Investment Research referenced Cowen & Company and GMP Securities in its list of analysts covering Canopy Growth, which received “buy” or “strong buy” ratings as well. Cronos Group, however, was covered only by two Canadian investment firms. At the end of the day, Wall Street analysts seem to be the most bullish on the company that has delivered the best stock performance, which is Tilray. The article noted that Tilray may be enticing investors’ because of its potential to land the next major deal, perhaps with Diageo (NYSE: DEO), a multinational alcoholic beverages company that is reportedly seeking a cannabis partner.
To view the full article, visit http://cnw.fm/lGR3E
About Tilray®
Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in eleven countries spanning five continents. For more information, visit the company’s website at www.Tilray.com.
More from CannabisNewsBreaks
About HempWire
HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and…
InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company developing small molecule drug candidates for diseases with…
CannabisNewsWire (CNW), a trusted communications platform within the cannabis sector and a part of InvestorBrandNetwork…
Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…
WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…
Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…